e-learning
resources
Virtual 2020
Pre-Congress Content
Unusual tools for evaluating obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inspiratory-to-total lung capacity ratio in COPD: the missed information
S. Mokaddem Mohsen (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Khaldi (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
Source:
Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Session:
Unusual tools for evaluating obstructive diseases
Session type:
E-poster session
Number:
167
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mokaddem Mohsen (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Khaldi (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). Inspiratory-to-total lung capacity ratio in COPD: the missed information. 167
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The main disease-related cost drivers in COPD: impaired lung function and exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 216s
Year: 2003
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Ventilation Heterogeneity in Asthma and COPD. The value of the poorly communicating fraction, as the ratio of total lung capacity to alveolar volume.
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Relationship between COPD assessment test (CAT) and declines of lung function in COPD patients
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 180s
Year: 2005
Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
COPD patients with exertional desaturation have a higher risk of rapid lung function decline
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Lung function and exercise capacity in COPD phenotypes with and without emphysema
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The contribution of lung hyperinflation to the reproducibility of arterial stiffness measurements in COPD: A comparison of techniques
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept